Alba Cespedes-Matas
BioPharmaceuticals R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized mice.
Journal: Frontiers in immunology
Published: November 25, 2022
3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma.
Journal: Cancers
Published: January 29, 2021
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies.
Journal: Cancer immunology, immunotherapy : CII
Published: August 19, 2020
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma.
Journal: Leukemia
Published: August 18, 2020
Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy-induced cytokine release syndrome.
Journal: Clinical & translational immunology
Published: July 07, 2020
Recent Advancements and Applications of Human Immune System Mice in Preclinical Immuno-Oncology.
Journal: Toxicologic pathology
Published: December 19, 2019
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens.
Journal: Haematologica
Published: November 13, 2018
The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status.
Journal: Haematologica
Published: August 26, 2017
Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma.
Journal: Journal of hematology & oncology
Published: December 29, 2016
The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 27, 2015
Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 07, 2014
Last Updated: 09/26/2026